Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Other Operating Expenses (2022 - 2025)

Catheter Precision (VTAK) has disclosed Other Operating Expenses for 7 consecutive years, with $1.8 million as the latest value for Q2 2025.

  • On a quarterly basis, Other Operating Expenses rose 222.95% to $1.8 million in Q2 2025 year-over-year; TTM through Sep 2025 was $2.0 million, a 102.48% increase, with the full-year FY2023 number at -$70.7 million, down 70.22% from a year prior.
  • Other Operating Expenses was $1.8 million for Q2 2025 at Catheter Precision, up from $119000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $4.7 million in Q2 2023 to a low of -$76.4 million in Q4 2023.
  • A 5-year average of -$5.2 million and a median of $119000.0 in 2025 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: crashed 74236.89% in 2023, then soared 301.69% in 2025.
  • Catheter Precision's Other Operating Expenses stood at $255000.0 in 2021, then plummeted by 59.61% to $103000.0 in 2022, then plummeted by 74236.89% to -$76.4 million in 2023, then skyrocketed by 98.35% to -$1.3 million in 2024, then soared by 246.55% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Other Operating Expenses are $1.8 million (Q2 2025), $119000.0 (Q1 2025), and -$1.3 million (Q3 2024).